æææ å ± ã·ã§ãã£ã³ã°ãããèã¿ã³ãã¯è³ªãé¸ã³åºãä»çµã¿ã解æâè² ã®é»è·ãæã¤ã¢ããé ¸ãã·ã§ãã£ã³ã°ãé»å®³ããâ ç«å½é¤¨å¤§å¦çå½ç§å¦é¨ã®ç½å£æåææãã®ç 究ã°ã«ã¼ãã¯ãæ±äº¬å»ç§æ¯ç§å¤§å¦ãä¹å·å¤§å¦ã大éªå¤§å¦ã¨ã®å ±åç 究ã§ãèããã±ã質ã®ç¹å®ã®é åã®ã¢ããé ¸é åãç´°èå¤ãã¡ã¤ã³ã·ã§ãã£ã³ã°ï¼ä»¥ä¸ãã·ã§ãã£ã³ã°ï¼ã«å¯¾ããæåæ§ã決ãã¦ãããã¨ã解æãããã¾ãããæ¬ç 究ææã¯ãå¦è¡èªãJournal of Biological Chemistryãã§çºè¡¨ããæ¡æç2ï¼ ç¨åº¦ã§ããEditors' Picksã«ãé¸åºããã¾ãããæ¬ç 究ã¯ãå½ç«ç 究éçºæ³äººæ¥æ¬å»çç 究éçºæ©æ§ã®é©æ°çå 端ç 究éçºæ¯æ´äºæ¥ï¼AMED-CRESTï¼ãçä½æ常æ§ç¶æã»å¤å®¹ã»ç ´ç¶»æ©æ§ã®ãããã¯ã¼ã¯çç解ã«åºã¥ãæé©å»çå®ç¾ã®ããã®æè¡åµåºãç 究éçºé åã«ãããç 究éçºèª²é¡ãç´°èéç¸äºä½ç¨ã¨èå¨ä»£è¬ãããã¯ã¼ã¯ã®ç ´ç¶»ã«ããçµç¹ç·ç¶
å®é¸ãã¼ã ãã¼ã¸ã®è³æã«ãã·ã§ãã£ã³ã°ã®æ¸å¿µã¯æè¨å ã ã·ã§ãã£ã³ã°ã¯çã¯ã¯ãã³ãä»è ã«ä¼æãææããç¾è±¡ éºä¼åæ²»çãåããæ£è ã®ããã®ã¦ã¤ã«ã¹/ãã¯ã¿ã¼ã®æåºãã·ã§ãã£ã³ã°ã¨å®ç¾©ã家æãå»çå¾äºè ã¸ä¼æãæ¸å¿µ ãã©ã¹ãããã¯ã¿ã¼ã§ãæ¸å¿µäºé ã§ããã®ã§DNAæ±æã§ãåé¡ã« å³ã¯é¦ç¸å®é¸ãã¼ã ãã¼ã¸ã®è³æ[1]ã«èµ¤ã§æ³¨é å ã ãã·ã§ãã£ã³ã°ã¯çã¯ã¯ãã³ãæ¥ç¨®ããã人ããæ¡æ£ããç¾è±¡ãæããçµæãä»ã®äººã«ä¼æ(transmission)ãããã¨ããããçã¯ã¯ãã³ã¯å¼±æ¯åããããç¡æ¯åãããã¦ã¤ã«ã¹ã§ãããããä¼æãææããã¨ããæ§è³ªãå¿ ãããç¡ããªã£ã¦ããããã§ã¯ç¡ãããã®ããèµ·ããå¾ãç¾è±¡ã§ããã éºä¼å製å¤ã«ãããã·ã§ãã£ã³ã°ã¯å½ãèªãããªã¹ã¯ã§ãããé¦ç¸å®é¸ãã¼ã ãã¼ã¸ã«å½ç«å»è¬åé£åè¡çç 究æã®è³æ[1]ãç½®ãã¦ããããã®ä¸ã§ãéºä¼åæ²»çãåããæ£è ã®ããã®ã¦ã¤ã«ã¹ããã¯ã¿ã¼ã®æåº(s
æ°åã³ããã¦ã¤ã«ã¹ã®æææ¡å¤§ãé²ãããã«ãã¹ã¯çç¨ãå¼ã³æããçæ¿ã2021å¹´ã®è±ãã³ãã³ã§ï¼2021å¹´12æ18æ¥æ®å½±ï¼ãã翻訳編éã AFPBB News ãAFPï¼æäºãæ°åã³ããã¦ã¤ã«ã¹ãçå¨ãæ¯ãã£ã2019ï½21å¹´ã«ä¸çã®å¹³å寿å½ï¼åºçæå¹³åä½å½ï¼ã¯2å¹´è¿ãçããªã£ãã¨ãã調æ»çµæãä¸çä¿å¥æ©é¢ï¼WHOï¼ã24æ¥ãä¸çä¿å¥çµ±è¨ã®2023å¹´çã§çºè¡¨ããã ãåçãã³ããæ»è ã40ä¸äººãè¶ ãéè·¯ãå¢å°ã« 2021å¹´ã®ãã©ã¸ã« å¹³å寿å½ã¨å¥åº·å¯¿å½ã¯çå®ã«ä¼¸ã³ã¦ããããæ°åã³ããã«ããå¾éããã¨ãã¦ããã WHOã®å¹´æ¬¡å ±åæ¸ã«ããã°ã2021å¹´ã®ä¸çã®å¹³å寿å½ã¯1.8æ³çããªãã71.4æ³ãå¥åº·å¯¿å½ã¯1.5æ³ç¸®ã¾ãã61.9æ³ããããã2012å¹´ã¨åæ°´æºã«è½ã¡è¾¼ãã ã è±å»å¦èªã©ã³ã»ããï¼The Lancetï¼ã«ä»å¹´1ææ²è¼ãããè«æã§ã¯ãæ°åã³ããã®æµè¡æã«å¹³å寿å½ã¯1.6æ³çããªã£
ä»åã¯ãæ°åã³ããã¦ã¤ã«ã¹ææç(COVID-19)ã®ææãã¯ã¯ãã³æ¥ç¨®ããã¢ã¬ã«ã®ã¼æ§æ¥è§¦ç®èçã®çºçã«ã©ã®ãããªå½±é¿ãä¸ããã®ããææ°ã®ç 究çµæããç´¹ä»ãã¾ãã ã¢ã¬ã«ã®ã¼æ§æ¥è§¦ç®èçã¨ã¯ãç¹å®ã®ç©è³ªã«ç®èãæ¥è§¦ãããã¨ã§å¼ãèµ·ããããã¢ã¬ã«ã®ã¼åå¿ã®ä¸ç¨®ã§ããããã¿ãçºèµ¤ãè «ããªã©ã®çç¶ãç¾ããå ´åã«ãã£ã¦ã¯æ°´ç±ãã§ãããã¨ãããã¾ããæ¥å¸¸çæ´»ã«æ¯éãããããã¨ããããããæ©æçºè¦ã¨é©åãªæ²»çã大åã§ãã ãããªã¢ã¬ã«ã®ã¼æ§æ¥è§¦ç®èçã§ãããå®ã¯COVID-19ã®ææãã¯ã¯ãã³æ¥ç¨®ãããã®çºçãªã¹ã¯ãé«ããå¯è½æ§ããããã¨ãæããã«ãªãã¾ãããç±³å½ã®ç 究ãã¼ã ã1,073人ã®æ£è ã対象ã«è¡ã£ãå¾ãåãç 究ã®çµæã以ä¸ã®ãããªå®æ ãæµ®ã彫ãã«ãªã£ãã®ã§ãã ãCOVID-19ææå¾ã«ã¢ã¬ã«ã®ã¼æ§æ¥è§¦ç®èçãçºçããã±ã¼ã¹ã ã¾ããCOVID-19ã®ææã確èªãããå¾ã«ã¢ã¬ã«ã®ã¼æ§æ¥è§¦ç®
ãã®ã³ã¼ãã¼ã§ã¯ã2014å¹´ããå 端ãã¯ããã¸ã¼ã®ç 究ãè«æåä½ã§è¨äºã«ãã¦ããWebã¡ãã£ã¢ãSeamlessãï¼ã·ã¼ã ã¬ã¹ï¼ã主宰ããå±±ä¸è£æ¯ æ°ãå·çãæ°è¦æ§ã®é«ãç§å¦è«æãå±±ä¸æ°ãããã¯ã¢ãããã解説ããã Twitter: ï¼ shiropen2 ã¤ã¹ã©ã¨ã«ã®ãã²ã´ã»ãã³ã»ã°ãªãªã³å¤§å¦ã«æå±ããç 究è ããçºè¡¨ããè«æãWhat Was Your Promptï¼ A Remote Keylogging Attack on AI Assistantsãã¯ã大è¦æ¨¡è¨èªã¢ãã«ï¼LLMï¼ãæ´»ç¨ããAIãã£ããbotãçæããããã¹ãåçã復å ãããµã¤ããã£ãã«æ»æãææ¡ããç ç©¶å ±åã§ãããæ»æè ã¯ãAIãã£ããbotãå¿çããéã®éä¿¡ãã¼ã¿ãååãããã¨ã§å 容ã復å ãã¦ä»äººã®ããã¨ããçã¿åºããã¨ãã§ããã æ»ææ¹æ³ã¨ãã¦ã¯ãã¾ãã¦ã¼ã¶ã¼ã¨LLMã®éã®æå·åããããã±ããéä¿¡ãååããã¨ããã
京é½å¤§å¦åèªææã®ç¦å³¶é å ¸æ°ãæ°åã³ããã¯ã¯ãã³å¾éºçã®èª¿æ»çµæã«ã¤ãã¦ã®è«èããæåãæèæ¥ç§ã4æå·ã§çºè¡¨ãããç¦å³¶æ°ã¯2023å¹´6æããã¯ã¯ãã³åé¡ç 究ä¼ãã¨ããå¦è¡å£ä½ãæå¿ã®å»å¸«ãã¨ç«ã¡ä¸ããã¯ã¯ãã³æ¥ç¨®å¾ã®å¥åº·è¢«å®³=ãã¯ã¯ãã³æ¥ç¨®å¾çå群ãã®ç 究ã«åãçµãã¹ããåã¤ã®ç®çãæ²ãããä¸çä¸ã®è«æã®ãã¼ã¿ãã¼ã¹åãçä¾ãã¼ã¿ãã¼ã¹ã®æ§ç¯ãæ¤æ»æ¹æ³ã®éçºãæ²»çæ¹æ³ã®ç¢ºç«ã ã ãç»åãæ¥æ¬å½å ã«ããã¦ã³ããã¯ã¯ãã³æ¥ç¨®å¾ãæ¥ã«çºçãããªã©ãå»å¦å¦ä¼ã§å ±åãæ¤è¨ãããç¾æ£ï¼2021å¹´12æï½2023å¹´11æï¼ ã³ããã¯ã¯ãã³ã®å¯ä½ç¨ã®åºæ¹ã¯åä¾ããªããã¾ããã¯ã¯ãã³æ¥ç¨®å¾çå群ãã©ãã»ã©å¤å²ã«ãããã®ããã示ããã¾ãããã 次é ã®è¡¨ã¯ãã¯ã¯ãã³æ¥ç¨®å¾ãæ¥ã«çºçãããªã©ããç¾æ£ã¨ãã¦ã2021å¹´12æãã2023å¹´11æã¾ã§ã®2å¹´éã«ãå½å ã®å»å¦å¦ä¼ã§å ±åã»æ¤è¨ãããç¾æ£ã®ä¸è¦§ã§ãï¼éå¬å¦
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}